Abstract:1887 Purposes: Reduced capacity to repair mutagen-induced DNA damage is implicated in susceptibility to cancer development. The nicotine-derived nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced lung adenocarcinogen through formation of DNA adducts. Methods: We used the comet assay to assess whether susceptibility to NNK-induced DNA damage was associated with increased risk of lung cancer in a hospital-based case-control study. We measured baseline and NNK-induced DNA damage in peripheral blood lymphocyte assays from 401 previously untreated Caucasian lung cancer cases and 388 matched healthy controls. DNA damage using NNK as the mutagen challenge was visualized with the comet assay and quantified by the Olive tail moment parameter. Multivariable analysis was used to assess risks for lung cancer associated with level of DNA damage. Results: The baseline levels of DNA damage were statistically significantly higher in cases than in controls (tail moments: 1.22±0.57 vs. 1.14±0.50, P =0.025), as were NNK-induced DNA damage (2.42±1.15 vs. 2.16±1.07, P =0.001). The net NNK-induced DNA damage (NNK-induced subtracted by baseline) was also significantly higher in cases compared with controls (1.20 vs. 1.03, P = 0.018). When data were dichotomized at the median value of olive tail moments in the controls and adjusted for age, sex, and smoking status, higher levels of net NNK-induced DNA damage were associated with a significantly increased lung cancer risk (odds ratio [OR] = 1.45, 95% CI = 1.09 to 1.94). In addition, there was also a significant dose effect. Compared to individuals in the lowest quartile of damage, the ORs for individuals in the second, third and fourth quartiles were 1.32 (95% CI: 0.86-2.03), 1.59 (95% CI: 1.04-2.43), and 1.78 (95% CI: 1.17-2.70), respectively (P-for trend =0.005). In stratified analysis, the elevated risk appeared to be higher in adenocarcinoma (OR=1.50, 95% CI: 1.05-2.13) than in other histologies (OR=1.38, 95% CI, 0.95-2.00), and higher in heavy smokers (OR=1.64, 95% CI: 1.09-2.47) than in light smokers (OR=1.49, 95% CI, 0.79-2.79). Conclusions: This is the first study to use NNK as a challenge mutagen in the comet assay. The results suggest that NNK-induced DNA damage is associated with an increased risk of lung adenocarcinoma and the net NNK-induced olive tail moment measure may serve as a useful predictor of lung cancer risk. Supported by NCI grants CA 55769, CA 70907 and CA 86390.

The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and Head and Neck Squamous Cancer Cells

Involvement of P53 Mutation and Mismatch Repair Proteins Dysregulation in NNK-Induced Malignant Transformation of Human Bronchial Epithelial Cells

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Nicotine Enhances Invasion and Metastasis of Human Colorectal Cancer Cells Through the Nicotinic Acetylcholine Receptor Downstream P38 MAPK Signaling Pathway.

Differential Expression of Micrornas in Early-Stage Neoplastic Transformation in the Lungs of F344 Rats Chronically Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone

NNK-induced DNA Damage As Measured by the Comet Assay is a Marker of Lung Cancer Risk

NF-κB Targets Mir-16 and Mir-21 in Gastric Cancer: Involvement of Prostaglandin E Receptors.

Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and β-adrenergic receptor signaling pathways

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

A novel four‐gene biomarker for tobacco smoking -induced colorectal cancer progression

Upregulated DNMT3a coupling with inhibiting p62-dependent autophagy contributes to NNK tumorigenicity in human bronchial epithelial cells

The Complexity of Tobacco Smoke-Induced Mutagenesis in Head and Neck Cancer

NNK-induced DNA methyltransferase 1 in lung tumorigenesis in A/J mice and inhibitory effects of (-)-epigallocatechin-3-gallate.

Nicotine downregulates miR-375–3p via neurotrophic tyrosine receptor kinase 2 to enhance the malignant behaviors of laryngopharyngeal squamous epithelial cells

Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma

Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK

Hypermethylation of the ADIRF promoter regulates its expression level and is involved in NNK-induced malignant transformation of lung bronchial epithelial cells

NNAL, a major metabolite of tobacco-specific carcinogen NNK, promotes lung cancer progression through deactivating LKB1 in an isomer-dependent manner

Mitotic Spindle Apparatus Abnormalities in Chronic Obstructive Pulmonary Disease Cells: A Potential Pathway to Lung Cancer.